Saundra L. Pelletier - 27 May 2022 Form 4 Insider Report for Evofem Biosciences, Inc. (EVFM)

Role
Chief Executive Officer, Director
Signature
/s/ Justin J. File, attorney-in-fact
Issuer symbol
EVFM
Transactions as of
27 May 2022
Net transactions value
+$49,702
Form type
4
Filing time
31 May 2022, 08:55:25 UTC
Previous filing
23 Feb 2022
Next filing
16 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVFM Common Stock Purchase $49,702 +141,000 +147% $0.3525 236,722 27 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased in multiple transactions and the price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.